These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 27344366)

  • 1. RNAi delivery by exosome-mimetic nanovesicles - Implications for targeting c-Myc in cancer.
    Lunavat TR; Jang SC; Nilsson L; Park HT; Repiska G; Lässer C; Nilsson JA; Gho YS; Lötvall J
    Biomaterials; 2016 Sep; 102():231-8. PubMed ID: 27344366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional exosome-mimic for delivery of siRNA to cancer: in vitro and in vivo evaluation.
    Yang Z; Xie J; Zhu J; Kang C; Chiang C; Wang X; Wang X; Kuang T; Chen F; Chen Z; Zhang A; Yu B; Lee RJ; Teng L; Lee LJ
    J Control Release; 2016 Dec; 243():160-171. PubMed ID: 27742443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.
    Lu M; Zhao X; Xing H; Liu H; Lang L; Yang T; Xun Z; Wang D; Ding P
    Acta Biomater; 2019 Sep; 96():517-536. PubMed ID: 31284098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer.
    Yang T; Fogarty B; LaForge B; Aziz S; Pham T; Lai L; Bai S
    AAPS J; 2017 Mar; 19(2):475-486. PubMed ID: 27882487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes are natural carriers of exogenous siRNA to human cells in vitro.
    Shtam TA; Kovalev RA; Varfolomeeva EY; Makarov EM; Kil YV; Filatov MV
    Cell Commun Signal; 2013 Nov; 11():88. PubMed ID: 24245560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors.
    Jang SC; Kim OY; Yoon CM; Choi DS; Roh TY; Park J; Nilsson J; Lötvall J; Kim YK; Gho YS
    ACS Nano; 2013 Sep; 7(9):7698-710. PubMed ID: 24004438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and Isolation of siRNA-Loaded Extracellular Vesicles.
    Vader P; Mäger I; Lee Y; Nordin JZ; Andaloussi SE; Wood MJ
    Methods Mol Biol; 2017; 1545():197-204. PubMed ID: 27943216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bio-inspired materials in drug delivery: Exploring the role of pulmonary surfactant in siRNA inhalation therapy.
    De Backer L; Cerrada A; Pérez-Gil J; De Smedt SC; Raemdonck K
    J Control Release; 2015 Dec; 220(Pt B):642-50. PubMed ID: 26363301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-Derived Nanovesicles as Exosome-Mimetics for Drug Delivery Purposes: Uses and Recommendations.
    Ou YH; Zou S; Goh WJ; Wang JW; Wacker M; Czarny B; Pastorin G
    Methods Mol Biol; 2021; 2211():147-170. PubMed ID: 33336276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering extracellular vesicles mimetics for targeted chemotherapy of drug-resistant ovary cancer.
    Liu X; Liu G; Mao Y; Luo J; Cao Y; Tan W; Li W; Yu H; Jia X; Li H
    Nanomedicine (Lond); 2024 Jan; 19(1):25-41. PubMed ID: 38059464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes.
    Wahlgren J; De L Karlson T; Brisslert M; Vaziri Sani F; Telemo E; Sunnerhagen P; Valadi H
    Nucleic Acids Res; 2012 Sep; 40(17):e130. PubMed ID: 22618874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery.
    Rayamajhi S; Nguyen TDT; Marasini R; Aryal S
    Acta Biomater; 2019 Aug; 94():482-494. PubMed ID: 31129363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of Small Interfering RNAs to Cells via Exosomes.
    Wahlgren J; Statello L; Skogberg G; Telemo E; Valadi H
    Methods Mol Biol; 2016; 1364():105-25. PubMed ID: 26472446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosome-mediated delivery of siRNA in vitro and in vivo.
    El-Andaloussi S; Lee Y; Lakhal-Littleton S; Li J; Seow Y; Gardiner C; Alvarez-Erviti L; Sargent IL; Wood MJ
    Nat Protoc; 2012 Dec; 7(12):2112-26. PubMed ID: 23154783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered extracellular vesicles with synthetic lipids via membrane fusion to establish efficient gene delivery.
    Jhan YY; Prasca-Chamorro D; Palou Zuniga G; Moore DM; Arun Kumar S; Gaharwar AK; Bishop CJ
    Int J Pharm; 2020 Jan; 573():118802. PubMed ID: 31715354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes from iPSCs Delivering siRNA Attenuate Intracellular Adhesion Molecule-1 Expression and Neutrophils Adhesion in Pulmonary Microvascular Endothelial Cells.
    Ju Z; Ma J; Wang C; Yu J; Qiao Y; Hei F
    Inflammation; 2017 Apr; 40(2):486-496. PubMed ID: 28000095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. siRNA Loaded-Exosomes.
    Izco M; Alvarez-Erviti L
    Methods Mol Biol; 2021; 2282():395-401. PubMed ID: 33928586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted exosome-mediated delivery of opioid receptor Mu siRNA for the treatment of morphine relapse.
    Liu Y; Li D; Liu Z; Zhou Y; Chu D; Li X; Jiang X; Hou D; Chen X; Chen Y; Yang Z; Jin L; Jiang W; Tian C; Zhou G; Zen K; Zhang J; Zhang Y; Li J; Zhang CY
    Sci Rep; 2015 Dec; 5():17543. PubMed ID: 26633001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of Exosomes for siRNA Delivery to Cancer Cells.
    Faruqu FN; Xu L; Al-Jamal KT
    J Vis Exp; 2018 Dec; (142):. PubMed ID: 30582600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosome-like Extracellular Vesicles from MYCN-amplified Neuroblastoma Cells Contain Oncogenic miRNAs.
    Haug BH; Hald ØH; Utnes P; Roth SA; Løkke C; Flægstad T; Einvik C
    Anticancer Res; 2015 May; 35(5):2521-30. PubMed ID: 25964525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.